| Title : A randomized phase I study of methanesulfonyl fluoride, an irreversible cholinesterase inhibitor, for the treatment of Alzheimer's disease - Moss_2013_Br.J.Clin.Pharmacol_75_1231 |
| Author(s) : Moss DE , Fariello RG , Sahlmann J , Sumaya I , Pericle F , Braglia E |
| Ref : British Journal of Clinical Pharmacology , 75 :1231 , 2013 |
| Abstract : Moss_2013_Br.J.Clin.Pharmacol_75_1231 |
| ESTHER : Moss_2013_Br.J.Clin.Pharmacol_75_1231 |
| PubMedSearch : Moss_2013_Br.J.Clin.Pharmacol_75_1231 |
| PubMedID: 23116458 |
Moss DE, Fariello RG, Sahlmann J, Sumaya I, Pericle F, Braglia E (2013)
A randomized phase I study of methanesulfonyl fluoride, an irreversible cholinesterase inhibitor, for the treatment of Alzheimer's disease
British Journal of Clinical Pharmacology
75 :1231
Moss DE, Fariello RG, Sahlmann J, Sumaya I, Pericle F, Braglia E (2013)
British Journal of Clinical Pharmacology
75 :1231